Holen Sie sich die Stockscreener-App
5.205
6.32%
-0.395
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight stock tumbles on reduced 2026 sales guidance By Investing.com - Investing.com Nigeria
Alcon, RxSight Begin Co-Developing Presbyopia-Correcting IOLs - Medical Product Outsourcing
Stifel reiterates Hold on RxSight stock, $8 target on Alcon deal By Investing.com - Investing.com Canada
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight - Yahoo Finance
RxSight reports preliminary Q2 revenue, revises 2026 guidance - MSN
RxSight (RXST) Reiterated at Hold by Stifel as ALC Collaboration Announced - StreetInsider
Rivian Automotive, Penguin Solutions And 3 Stocks To Watch Heading Into Tuesday - Benzinga
RXST: 2026 revenue guidance lowered, gross margin raised, and next-gen lens pipeline advances - TradingView
Alcon, RxSight Partner to Develop Adjustable Presbyopia-Correcting IOLs - VisionMonday.com
RxSight raises FY26 sales guidance to $140M-$160M - scanx.trade
Alcon (ALC) Partners with RxSight for Innovative Lens Developmen - GuruFocus
RxSight reports Q2 revenue of $32-34M, cuts 2026 sales outlook - Investing.com
Alcon, RxSight partner on adjustable lens technology By Investing.com - Investing.com South Africa
RxSight says Q2 results hit by more widespread competitive trialing - TradingView
RxSight cuts 2026 sales outlook, citing competitive headwinds - StreetInsider
RxSight (NASDAQ: RXST) cuts 2026 sales outlook but lifts margin view - Stock Titan
RxSight sees Q2 sales of $27M as Alcon deal adds revenue - Stock Titan
Join Class Action to Recover Losses From RxSight, Inc. (RXST)Contact Levi & Korsinsky Before September 22, 2025 - The National Law Review
RXSTRxSight Inc Options - Finviz
Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST - The National Law Review
RxSight, Inc.(NasdaqGM: RXST) dropped from Russell 2500 Growth Benchmark - marketscreener.com
RxSight Inc. (RXST) Declines Nearly 5% as Stock Approaches Critical SupportOvervalued Signals - dars.gov.et
RxSight, Inc.(NasdaqGM: RXST) added to Russell Microcap Value Benchmark Index - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) added to Russell 2000 Value Benchmark - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) dropped from Russell 2000 Growth Benchmark - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) dropped from Russell 3000E Growth Benchmark - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) added to Russell Microcap Index - marketscreener.com
Class Action Alert: Levi & Korsinsky Reminds RxSight, Inc. (RXST) Investors of September 22, 2025 Deadline - The National Law Review
Liquidity Mapping Around (RXST) Price Events - Stock Traders Daily
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
RXST Stockholders Have Opportunity to Lead RxSight, Inc. Class Ac - The National Law Review
RxSight, Inc. (RXST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 22, 2025 Deadline - The National Law Review
Class Action Lawsuit Filed: RxSight, Inc. (RXST)Join by September 22, 2025Contact Levi & Korsinsky - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - The National Law Review
Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky Before September 22, 2025 to Join Class Action - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
RXST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Investors Urged to Contact Levi & Korsinsky For Information Before September 22, 2025RxSight, Inc. (RXST) - The National Law Review
RXST Forecast — Price Target — Prediction for 2027 - TradingView
RxSight, Inc. Actuals & Estimates (NASDAQ:RXST) - TradingView
RxSight, Inc. Actuals & Estimates (BOATS:RXST) - TradingView
Rxsight Inc (RXST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
RXST SEC FilingsRxsight, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Rxsight Inc (RXST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
RxSight (RXST) director receives 37,037 restricted stock units in equity grant - Stock Titan
RxSight (RXST) director awarded 37,037 RSUs in equity compensation grant - Stock Titan
RxSight (RXST) director Shweta Maniar receives 37,037 RSU award - Stock Titan
Tamara Fountain at RxSight (RXST) receives 37,037-share RSU award - Stock Titan
RxSight (RXST) director William J. Link granted 37,037-share stock award - Stock Titan
RxSight (RXST) director Corley Jesse Anderson granted 37,037 RSUs - Stock Titan
RxSight (RXST) director granted 30,864 RSUs vesting by next meeting - Stock Titan
RxSight (RXST) director receives 37,037 RSUs vesting by next stockholder meeting - Stock Titan
RxSight (RXST) director receives 37,037 RSUs, now directly holds 85,183 shares - Stock Titan
Rxsight Inc (RXST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rxsight Inc (RXST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
RxSight Stockholders Back Leadership at 2026 Annual Meeting - The Globe and Mail
Rxsight Inc (RXST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rxsight Inc (RXST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rxsight Inc (RXST) Institutional Confidence - TradingKey
0.18%
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):